drugset / Trial / NCT03497039

A Study to Characterize Diclofenac's Plasma and Knee Exposure After Application of Diclofenac Gel to the Knee of Subjects With Osteoarthritis That Have a Scheduled Arthroplasty

NCT03497039

Phase 1 Completed 47 enrolled GlaxoSmithKline
RandomizedParallel-groupQuadruple-blindOther

Summary

The purpose of this study is to evaluate the exposure of diclofenac in the plasma and in the knee joint following topical administration of DDEA gel 4 gram (g) applied twice daily for 7 days.

Timeline

Start
2018-07-19
Primary completion
2019-03-01
Completion
2019-03-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Diclofenac diethylamine Unknown 2.32 % Topical
Subject Diclofenac diethylamine Unknown 4 g Topical

Indications

No indication recorded.